Related Experiment Videos
Relation between upper limit of vulnerability and defibrillation threshold in humans
P S Chen1, G K Feld, J M Kriett
1Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Circulation
|July 1, 1993
Summary
An upper limit of vulnerability exists in humans, demonstrating a significant correlation with the defibrillation threshold. This limit is notably lower than the defibrillation threshold, impacting device safety.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Device Technology
Background:
- An upper limit of vulnerability (ULV) exists in canines, correlating with defibrillation threshold (DFT).
- The existence and correlation of ULV with DFT in humans remained undetermined.
- Understanding ULV is crucial for implantable cardioverter-defibrillator (ICD) safety and efficacy.
Purpose of the Study:
- To determine if an upper limit of vulnerability exists in humans.
- To investigate the correlation between the upper limit of vulnerability and the defibrillation threshold in patients.
- To assess the safety of determining ULV during ICD implantation.
Main Methods:
- The up-down algorithm was used to determine the shock strengths for 50% probability of reaching the upper limit of vulnerability (ULV50) and defibrillation threshold (DFT50) in 13 patients.
- ULV50 was assessed during specific phases of the cardiac cycle (T waves).
- No major complications were reported during the procedures.
Main Results:
- An upper limit of vulnerability was demonstrated in all tested patients.
- The ULV50 (300 ± 138 V or 6.8 ± 5.8 J) was significantly lower than the DFT50 (347 ± 167 V or 9.1 ± 7.3 J).
- A strong significant correlation was found between ULV50 and DFT50 (r = 0.90 for voltage, r = 0.93 for energy).
Conclusions:
- An upper limit of vulnerability is present in human subjects.
- The ULV50 is significantly lower than the DFT50 in humans.
- A significant correlation exists between ULV50 and DFT50, supporting its relevance in defibrillation.